Focus of Study: Drug Response Biomarkers, Chemoprevention, Neoplasms
1 clinical trials · Condition
◉ Watch Focus of Study: Drug Response Biomarkers, Chemoprevention, Neoplasms
| Record | Firm | Date |
|---|---|---|
| Urinary Biomarker Study With Sulindac and Difluoromethylornithine (NCT01636128) | Cancer Prevention Pharmaceuticals, Inc. | 2014-03-01 |
Track Focus of Study: Drug Response Biomarkers, Chemoprevention, Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.